Valued at $1.0B at its early-stage round, Jan 2026. Nothing has traded since.
- ·The complete investor list: 17 names
- ·Watch Mirador Therapeutics: the Monday email on marks, rounds and moves
Valuation timeline
0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026Membership and data by Private Market View
Mirador Therapeutics funding history
2 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Feb 2024 | Later Stage VC | $333.0M | ▮ | ▮ |
| Dec 2023 | Later Stage VC | $80.0M | ▮ | ▮ |
Membership and data by Private Market View
Mirador Therapeutics valuation
Mirador Therapeutics was valued at $1 billion at its early-stage round in Jan 2026. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
How much has Mirador Therapeutics raised?
Mirador Therapeutics has raised $735 million in total; 2 of its rounds are on record. The largest on record was an $80 million later-stage round in Dec 2023; the most recent was a $333 million later-stage round in Feb 2024.
Mirador Therapeutics has filed 2 Form Ds with the SEC, most recently in Apr 2024 ($80 million sold to 3 investors).
How Mirador Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Mirador Therapeutics, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →
Frequently asked about Mirador Therapeutics
- What is Mirador Therapeutics worth?
- Mirador Therapeutics is valued at $1.0B as of Oct 2026. Valued at $1.0B at its early-stage round, Jan 2026. Nothing has traded since.
- How much has Mirador Therapeutics raised?
- Mirador Therapeutics has raised $735.0M in total funding across 2 recorded rounds.
- When did Mirador Therapeutics last raise?
- Mirador Therapeutics last raised in Feb 2024 (Later Stage VC), raising $333.0M.